Mass General Brigham has created a collaborative community to accelerate the development of implantable brain-computer interface (BCI) devices.
The group, which Mass General Brigham disclosed Monday, brings BCI experts together with the Food and Drug Administration and other organizations to develop harmonized approaches to the technology.
The collaborators aim to resolve the clinical, regulatory, coverage and payment questions facing developers of BCIs and thereby try to improve patient access to the technology.